Journals / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 4

Genetic and Clinical Demographics of Adult Cystic Fibrosis Patients in a Middle Eastern Population

Pages
279–283
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Late diagnosis, high pseudomonas colonization rate, and exacerbation frequency remain a problem in this region and lead to poor long-term outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Cystic fibrosis (CF) is the commonest life-limiting inherited illness in the Caucasian population but is uncommon in the Middle East, and so the genotypes and clinical course of disease in this population is not well known.MATERIAL AND METHODS: In this retrospective observational study, we collected and reviewed the data on CF mutations, body mass index (BMI), lung function, microbiology, and the demographics in adult CF patients in the United Arab Emirates (UAE).RESULTS: Data was reviewed for 39 adult CF patients.
📊
Key Findings & Data:The median age of adult CF patients presenting to our clinic was 25 years (interquartile range (IQR) 22-31), the median BMI was 19 (IQR 17-22), and the median percentage predicted forced expiratory volume at 1 second (FEV1) was 49.5% (IQR 38.5-62.5).
💡
Conclusion & Impact:Late diagnosis, high pseudomonas colonization rate, and exacerbation frequency remain a problem in this region and lead to poor long-term outcomes.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: Cystic fibrosis (CF) is the commonest life-limiting inherited illness in the Caucasian population but is uncommon in the Middle East, and so the genotypes and clinical course of disease in this population is not well known.MATERIAL AND METHODS: In this retrospective observational study, we collected and reviewed the data on CF mutations, body mass index (BMI), lung function, microbiology, and the demographics in adult CF patients in the United Arab Emirates (UAE).RESULTS: Data was reviewed for 39 adult CF patients. The median age of adult CF patients presenting to our clinic was 25 years (interquartile range (IQR) 22-31), the median BMI was 19 (IQR 17-22), and the median percentage predicted forced expiratory volume at 1 second (FEV1) was 49.5% (IQR 38.5-62.5). S549R was the commonest mutation (n = 11, 28%) followed by ∆F508 (n = 9, 23%). Only 5 (13%) out of 39 patients were heterozygote for CF mutations which reflects the high level of consanguinity in the region. Twelve (30%) patients were diagnosed after the age of 16, and in total, 19 (48%) were diagnosed after the age of 10. Thirty-two (82%) of patients are pseudomonas colonized, and 31% had 3 or more exacerbations in the last 12 months.CONCLUSION: The CF mutation patterns in the UAE are different from western populations with low ∆F508 prevalence, with the presence of rare mutations more specific to this region and a high rate of homozygosity. Late diagnosis, high pseudomonas colonization rate, and exacerbation frequency remain a problem in this region and lead to poor long-term outcomes.

🔖

Cite This Article

SHAFIQ, I., SHABEER, S., UZBECK, M. H., ZOUMOT, Z., ABUZAKOUK, M., WAHLA, A. S. (2021). Genetic and Clinical Demographics of Adult Cystic Fibrosis Patients in a Middle Eastern Population. Turkish Thoracic Journal, Cilt: 22 - Sayı: 4, 279–283. https://ajindex.com/articles/417891

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Davies JC, Alton EWFW, Bush A. Cystic fibrosis. BMJ. 2007;335:1255-1259. [CrossRef] 2. UK Cystic Fibrosis Registry Annual Data Report. https://www. cysticfibrosis.org.uk; 2018;2019. 3. Salam MZ. Cystic fibrosis of the pancreas in an oriental child. Ann Paediatr Int Rev Pediatr. 1958;190:252-255. 4. El Gohary A, Salem FA, Aziz SA. Cystic fibrosis in the UAE. Emirates Med J. 1991;9:202-204. 5. Frossard PM, Lestringant G, Girodon E, Goossens M, Dawson KP. Determination of the prevalence of cystic fibrosis in the united arab emirates by genetic carrier screening. Clin Genet. 1999;55:496-497. [CrossRef] 6. MacKenzie T, Gifford AH, Sabadosa KA et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry. Ann Intern Med. 2014;161:233-241. [CrossRef] 7. Stephenson AL, Sykes J, Stanojevic S et al. Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study. Ann Intern Med. 2017;166:537-546. [CrossRef] 8. Banjar H, Angyalosi G. The road for survival improvement of cystic fibrosis patients in arab countries. Int J Pediatr Adolesc Med. 2015;2:47-58. [CrossRef] 9. Sharma R, Florea VG, Bolger AP et al. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax. 2001;56:746-750. [CrossRef] 10. Hector A, Kirn T, Ralhan A et al. Microbial colonization and lung function in adolescents with cystic fibrosis. J Cyst Fibros. 2016;15:340-349. [CrossRef] 11. Frossard PM, Girodon E, Dawson KP et al. Identification of cystic fibrosis mutations in the united arab emirates. Mutations in brief no. 133. Hum Mutat. 1998;11:412-413. [CrossRef] 12. Rodman DM, Polis JM, Heltshe SL et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med. 2005;171:621-626. [CrossRef] 13. Green A, Isherwood D, Pollitt R. Cystic_Fibrosis_Lab_Guide_ February_2014_v1.0_12_.pdf [Internet]. Accessed 2020 Jan 24. https://assets.publishing.service.gov.uk/government/uploads/ system/uploads/attachment_data/file/397726/Cystic_Fibrosis_L ab_Guide_February_2014_v1.0_12_.pdf.